The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTI Fluid Systems Regulatory News (TIFS)

Share Price Information for TI Fluid Systems (TIFS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.80
Bid: 140.60
Ask: 141.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.284%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 140.80
TIFS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Over-allotment Option

24 Nov 2017 07:00

RNS Number : 4126X
TI Fluid Systems PLC
24 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT

For immediate release

23 November 2017

 

TI Fluid Systems plc

 

Exercise of Over-allotment Option

Goldman Sachs International ("Goldman Sachs"), acting as the Stabilisation Manager in connection with the initial public offering (the "Global Offer") of TI Fluid Systems plc (the "Company") has today given notice to exercise the over-allotment option (the "Over-allotment Option") granted by funds advised by Bain Capital Private Equity LP (the "Over-allotment Shareholders") in respect of 5,645 ordinary shares of the Company (the "Over-allotment Shares") at the offer price of 255 pence per Over-allotment Share. The Company did not participate in the Over-allotment Option.

Including the exercise of the Over-allotment Option, the final total size of the Global Offer was £406,692,414 (159,487,221 ordinary shares), in total representing 31 per cent of the ordinary shares of the Company currently in issue.

DISCLAIMER / FORWARD-LOOKING STATEMENTS

Important notice

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, any securities to any person in any jurisdiction, including the United States, Australia, Canada or Japan, to whom or in which such offer or solicitation is unlawful.

The securities to which this announcement relates have not been and will not be registered under the US Securities Act or with any regulatory authority or under any applicable securities laws of any state or other jurisdiction of the United States, and may not be offered or sold within the United States absent registration under the US Securities Act or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with applicable state law. There will be no public offer of the securities in the United States. Any securities sold in the United States will be sold only to qualified institutional buyers, as defined in, and in reliance on, Rule 144A under the US Securities Act or pursuant to another exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act.

J.P. Morgan Securities plc ("J.P. Morgan") and Goldman Sachs International ("Goldman Sachs") have been appointed as joint sponsors, Deutsche Bank AG, London Branch ("Deutsche Bank"), Goldman Sachs and J.P. Morgan have been appointed as joint global co-ordinators and joint bookrunners, Citigroup Global Markets Limited ("Citigroup") has been appointed as joint bookrunner, HSBC Bank plc ("HSBC") has been appointed as lead manager and Lazard & Co., Limited has been appointed as financial adviser (together, the "Banks"). Deutsche Bank is authorised under German Banking Law (competent authority: European Central Bank) and, in the United Kingdom, by the Prudential Regulation Authority (the "PRA"). It is subject to supervision by the European Central Bank and by BaFin, Germany's Federal Financial Supervisory Authority, and is subject to limited regulation in the United Kingdom by the PRA and the Financial Conduct Authority (the "FCA"). Deutsche Bank is a corporation domiciled in Frankfurt am Main, Germany, operating in the United Kingdom under branch registration number BR000005, acting through its London branch. Each of Goldman Sachs, J.P. Morgan, Citigroup and HSBC is authorised by the PRA and regulated by the FCA and the PRA. Lazard is authorised and regulated by the FCA. The Banks are acting exclusively for the Company and no one else in connection with the Global Offer, will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Global Offer and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients nor for giving advice in relation to the Global Offer, Admission or any transaction or arrangement referred to in this announcement.

In connection with the Global Offer, each of the Banks and any of their respective affiliates, acting as investors for their own accounts, may purchase Ordinary Shares and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Ordinary Shares and other securities of the Company or related investments in connection with the Global Offer or otherwise. Accordingly, references in the Prospectus to the Ordinary Shares being offered, subscribed, issued, acquired, sold, placed or otherwise dealt in should be read as including any offer, subscription, issue, sale, acquisition, placing or dealing in the Ordinary Shares by any of the Banks and any of their affiliates acting as investors for their own accounts. In addition, certain of the Banks or their affiliates may enter into financing arrangements and swaps in connection with which they or their affiliates may from time to time acquire, hold or dispose of Ordinary Shares. None of the Banks nor any of their respective affiliates intends to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

Apart from the responsibilities and liabilities, if any, which may be imposed on any of the Banks by the FSMA or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, none of Banks or any of their respective affiliates, directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFEUEFDFWSEEF
Date   Source Headline
10th Nov 20214:36 pmRNSProposed Placing of shares in TI Fluid Systems plc
8th Nov 20215:15 pmRNSHolding(s) in Company
4th Nov 20217:00 amRNSQ3 2021 Trading Update
1st Nov 20217:00 amRNSNotice of Q3 2021 Trading Update
21st Sep 20211:00 pmRNSNEW CEO AND ADDITIONS TO THE EXECUTIVE COMMITTEE
23rd Aug 20217:00 amRNSInterim dividend - Payment of dividend in Sterling
11th Aug 20218:00 amRNSInterim dividend
9th Aug 20217:00 amRNSResults for the six months ended 30 June 2021
4th Aug 202112:00 pmRNSAppointment of Independent Non-Executive Director
23rd Jul 20216:08 pmRNSDirector/PDMR Shareholding
13th May 20213:30 pmRNSResults of Annual General Meeting 2021
12th May 20217:00 amRNSQ1 2021 Trading Update
20th Apr 202110:00 amRNSHolding(s) in Company
19th Apr 20214:30 pmRNSDirector/PDMR Shareholding
16th Apr 20217:00 amRNSResults of Placing
15th Apr 20215:18 pmRNSSale of Shares
6th Apr 20217:00 amRNSAnnual Report and Accounts 2020 & AGM 2021
17th Mar 20217:00 amRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSResults for the 12 months ended 31 December 2020
11th Mar 20217:00 amRNSDirectorate Change
17th Feb 20217:00 amRNSWilliam L. Kozyra to retire as President & CEO
9th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSInterim dividend - Payment of dividend in Sterling
25th Jan 20217:00 amRNSPost Close Trading Update
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSQ3 2020 Trading Update
24th Sep 20207:00 amRNSDirector/PDMR Shareholding
24th Aug 20207:00 amRNSAppointment of Joint Broker
18th Aug 20207:00 amRNSResults for the six months ended 30 June 2020
17th Jun 20207:00 amRNSDirector/PDMR Shareholding
14th May 20203:15 pmRNSResult of AGM
11th May 20207:00 amRNSQ1 2020 Trading Update and Final Dividend for 2019
24th Apr 20204:41 pmRNSSecond Price Monitoring Extn
24th Apr 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20204:40 pmRNSSecond Price Monitoring Extn
23rd Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSAnnual Report and Accounts 2019 and AGM 2020
27th Mar 20204:00 pmRNSDirector/PDMR Shareholding
17th Mar 20207:00 amRNSResults for the 12 months ended 31 December 2019
27th Jan 20207:00 amRNSPost-Close Trading Statement
12th Dec 20194:00 pmRNSCommittee Changes
12th Dec 20197:00 amRNSAppointment of Non-Executive Director
6th Dec 20197:00 amRNSDirector/PDMR Shareholding
4th Dec 20197:00 amRNSDirector/PDMR Shareholding
20th Nov 20194:00 pmRNSDirector/PDMR Shareholding
18th Nov 20197:00 amRNSDirectorate Change
12th Nov 20197:00 amRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSQ3 2019 Trading Update
5th Nov 20197:00 amRNSAppointment of new Senior Independent Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.